McKesson Corporation

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, COR has a market cap of 68.1B. Regarding current trading prices, MCK is priced at $943.37, while COR trades at $347.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas COR's P/E ratio is 41.95. In terms of profitability, MCK's ROE is -2.45%, compared to COR's ROE of +1.01%. Regarding short-term risk, MCK is less volatile compared to COR. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check COR's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, CAH has a market cap of 51.1B. Regarding current trading prices, MCK is priced at $943.37, while CAH trades at $217.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas CAH's P/E ratio is 31.17. In terms of profitability, MCK's ROE is -2.45%, compared to CAH's ROE of -0.59%. Regarding short-term risk, MCK is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for MCK.Check CAH's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, MCK is priced at $943.37, while ABC trades at $179.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas ABC's P/E ratio is 21.92. In terms of profitability, MCK's ROE is -2.45%, compared to ABC's ROE of +1.01%. Regarding short-term risk, MCK is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for MCK.Check ABC's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, HSIC has a market cap of 8.9B. Regarding current trading prices, MCK is priced at $943.37, while HSIC trades at $74.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas HSIC's P/E ratio is 23.11. In terms of profitability, MCK's ROE is -2.45%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, MCK is less volatile compared to HSIC. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check HSIC's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, PBH has a market cap of 3B. Regarding current trading prices, MCK is priced at $943.37, while PBH trades at $61.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas PBH's P/E ratio is 16.20. In terms of profitability, MCK's ROE is -2.45%, compared to PBH's ROE of +0.10%. Regarding short-term risk, MCK is more volatile compared to PBH. This indicates potentially higher risk in terms of short-term price fluctuations for MCK.Check PBH's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, MCK is priced at $943.37, while PDCO trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas PDCO's P/E ratio is 20.48. In terms of profitability, MCK's ROE is -2.45%, compared to PDCO's ROE of +0.06%. Regarding short-term risk, MCK is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for MCK.Check PDCO's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, GRDN has a market cap of 2.1B. Regarding current trading prices, MCK is priced at $943.37, while GRDN trades at $32.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas GRDN's P/E ratio is 47.85. In terms of profitability, MCK's ROE is -2.45%, compared to GRDN's ROE of +0.27%. Regarding short-term risk, MCK is less volatile compared to GRDN. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check GRDN's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, MCK is priced at $943.37, while OMI trades at $2.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas OMI's P/E ratio is -0.47. In terms of profitability, MCK's ROE is -2.45%, compared to OMI's ROE of +7.33%. Regarding short-term risk, MCK is less volatile compared to OMI. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check OMI's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, ACH has a market cap of 182M. Regarding current trading prices, MCK is priced at $943.37, while ACH trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas ACH's P/E ratio is -1.78. In terms of profitability, MCK's ROE is -2.45%, compared to ACH's ROE of +7.33%. Regarding short-term risk, MCK is less volatile compared to ACH. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check ACH's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, GEG has a market cap of 56.3M. Regarding current trading prices, MCK is priced at $943.37, while GEG trades at $2.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas GEG's P/E ratio is -4.16. In terms of profitability, MCK's ROE is -2.45%, compared to GEG's ROE of -0.21%. Regarding short-term risk, MCK is less volatile compared to GEG. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check GEG's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, MCK is priced at $943.37, while HX trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas HX's P/E ratio is -1.84. In terms of profitability, MCK's ROE is -2.45%, compared to HX's ROE of -1.07%. Regarding short-term risk, MCK is less volatile compared to HX. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check HX's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, RDGT has a market cap of 12.5M. Regarding current trading prices, MCK is priced at $943.37, while RDGT trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas RDGT's P/E ratio is -8.19. In terms of profitability, MCK's ROE is -2.45%, compared to RDGT's ROE of +0.40%. Regarding short-term risk, MCK is less volatile compared to RDGT. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check RDGT's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, SNYR has a market cap of 12.1M. Regarding current trading prices, MCK is priced at $943.37, while SNYR trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas SNYR's P/E ratio is 4.82. In terms of profitability, MCK's ROE is -2.45%, compared to SNYR's ROE of -0.20%. Regarding short-term risk, MCK is less volatile compared to SNYR. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check SNYR's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, WGRX has a market cap of 11.4M. Regarding current trading prices, MCK is priced at $943.37, while WGRX trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas WGRX's P/E ratio is -0.13. In terms of profitability, MCK's ROE is -2.45%, compared to WGRX's ROE of -15.47%. Regarding short-term risk, MCK is less volatile compared to WGRX. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check WGRX's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, ZYXI has a market cap of 1.8M. Regarding current trading prices, MCK is priced at $943.37, while ZYXI trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas ZYXI's P/E ratio is -0.02. In terms of profitability, MCK's ROE is -2.45%, compared to ZYXI's ROE of -18.07%. Regarding short-term risk, MCK is less volatile compared to ZYXI. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check ZYXI's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, MEHA has a market cap of 1.3M. Regarding current trading prices, MCK is priced at $943.37, while MEHA trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas MEHA's P/E ratio is -3.86. In terms of profitability, MCK's ROE is -2.45%, compared to MEHA's ROE of -1.69%. Regarding short-term risk, MCK is less volatile compared to MEHA. This indicates potentially lower risk in terms of short-term price fluctuations for MCK.Check MEHA's competition here

MCK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCK stands at 116.1B. In comparison, CVET has a market cap of 0. Regarding current trading prices, MCK is priced at $943.37, while CVET trades at $20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCK currently has a P/E ratio of 27.15, whereas CVET's P/E ratio is -69.97. In terms of profitability, MCK's ROE is -2.45%, compared to CVET's ROE of -0.06%. Regarding short-term risk, MCK is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for MCK.Check CVET's competition here